Literature DB >> 824953

The effect of antibiotic prophylaxis on patients undergoing total abdominal hysterectomy. II. Alterations of microbial flora.

M J Ohm, R P Galask.   

Abstract

Preoperative cultures of the endocervix were taken on 93 women who subsequently underwent total abdominal hysterectomy and received a 5 day course of either prophylactic cephalosporins or placebo. Postoperative cultures of the vaginal apex were taken on 86 of these women 5 days after surgery, i.e. 1 day after the cessation of study medication. Comparisons of the preoperative and postoperative flora in both the active drug and placebo groups as well as comparisons between the postoperative flora of the drug group and that of the placebo group were made. Postoperative alterations of bacterial flora occurred whether or not the patient received prophylactic antibiotics.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824953     DOI: 10.1016/0002-9378(76)90357-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Antibiotic prophylaxis for elective hysterectomy.

Authors:  Reuben Olugbenga Ayeleke; Selma Mourad; Jane Marjoribanks; Karim A Calis; Vanessa Jordan
Journal:  Cochrane Database Syst Rev       Date:  2017-06-18

Review 2.  Antibiotic prophylaxis in hysterectomy and induced abortion. A review of the evidence.

Authors:  E T Houang
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Double-blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy.

Authors:  J Vincelette; F Finkelstein; F Y Aoki; R I Ogilvie; G K Richards; R J Seymour
Journal:  Can Med Assoc J       Date:  1982-07-15       Impact factor: 8.262

4.  Trends in bacterial resistance among perioperative infections in patients with primary ovarian cancer: A retrospective 20-year study at an affiliated hospital in South China.

Authors:  Yanlin Zhou; Tingting Zhang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.